A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease Article
Full Text via DOI: 10.1158/1538-7445.AM2014-CT302
Web of Science: 000349910205069